Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
COCHLEAR LIMITED (COH)ASX AI Signals has generated 4 signal for COH during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest COH Signals | |
| 11/05/2026 | BUY |
| 10/05/2026 | BUY |
| 09/05/2026 | BUY |
COH Share Price | |
| Current Price | $124.960 |
| 52 Week High | $313.147 |
| 52 Week Low: | $90.000 |
| Trading at (% of 52 Week High) | 39.90% |
Cochlear Limited (ASX: COH) is a global leader in implantable hearing solutions. The company designs, manufactures, and supplies cochlear implants and other hearing devices to help people with hearing loss. Cochlear operates in multiple countries, providing advanced technology to improve hearing and communication.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Cochlear Limited demonstrates strong market positioning in the medical devices sector with consistent revenue growth and innovation in hearing implant technology. The current valuation reflects reasonable upside potential supported by robust demand trends and expanding global markets. However, exposure to regulatory risks and currency fluctuations warrants cautious optimism.
Dr. Candice Colby‑Scott shares how cochlear implants can help people reconnect, and why thinking ahead about care, including MRI access, matters
LONE TREE, Colo., June 26, 2026 /PRNewswire/ --Â Summer is a season for social events, backyard barbecues, family vacations, and long conversations with fr Custom Market Insights
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Ear Health Market size & share revenue was valued at approximately USD 10.12 Billion in 2025 and is expected to reach USD 10.82 Billion in 2026 an During Better Hearing and Speech Month, understanding MRI compatibility is an important part of long-term hearing care
LONE TREE, Colo., May 29, 2026 /PRNewswire/ -- May is Better Hearing and Speech Month, a month dedicated to raising awareness about the importance of hearing health. For the millio This article first appeared on GuruFocus.
Cochlear Ltd. (CHEOY) shares moved sharply lower in early Sydney trading on Wednesday, falling as much as 39% and marking the company's steepest decline since its 1995 initial public offering. The move followed a meaningful reset to its fiscal-year outlook, The new Cochlear™ Nucleus® Nexa® System is the first and only hearing implant featuring internal memory and upgradeable firmware. Approximately 63 million people in India suffer from significant auditory impairment, representing about 6.3% of the Indian population.
MUMBAI, India, March 2, 2026 /PRNLatest COCHLEAR LIMITED(COH) News
Don't Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health
[Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants
Cochlear Shares Plunge 39% After Profit Guidance Cut
This World Hearing Day, Cochlear brings the world's first and only smart hearing implant system to India
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial